ELAVL4 and Parkinson disease: Notably, kinases like LRRK2 (commonly mutated in familial PD) can phosphorylate HuD, a modification that may alter its RNA-binding properties and indirectly lead to abnormal expression of multiple downstream genes, thereby contributing to PD pathology [47,103].